$FOXO

Top 3 Tech Stocks That Could Lead To Your Biggest Gains In July - FOXO Technologies (AMEX:FOXO), ClearOne (NASDAQ:CLRO)

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.

Original reporting
Benzinga · Avi Kapoor
Published Jul 1, 2025, 10:41 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2025, 11:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Top 3 Tech Stocks That Could Lead To Your Biggest Gains In July - FOXO Technologies (AMEX:FOXO), ClearOne (NASDAQ:CLRO) — source image
Decision brief

The 30-second read

$FOXOBullishMed
01

Why it matters

Technical oversold signals suggest a possible rebound, but fundamental factors remain unassessed.

02

Market read

The focus is on US-listed technology stocks with technical signals indicating potential short-term gains.

03

What to watch

Fundamental analysis and upcoming earnings reports could significantly alter stock trajectories, which are not accounted for in this technical-focused assessment.

Timing: High in July, aligning with the news publication date.

Background

The article emphasizes technical indicators, specifically RSI, to identify undervalued tech stocks with potential for gains in July.

Company-level read

Ticker impact

$FOXOBullishMedium confidence
Context

Top tech stock highlighted for potential gains in July based on undervaluation and oversold conditions.

Expected impact

Moderate upward movement expected if technical signals confirm.

Evidence & confidence

Technical indicators show oversold conditions, but lack of recent fundamental news limits confidence.

$CLROBullishMedium confidence
Context

Listed as somewhat-bullish with moderate relevance; potential for gains but less certain.

Expected impact

Potential slight increase; significant gains less likely.

Evidence & confidence

Relevance score indicates moderate impact; technical and sentiment signals support cautious optimism.

$IMOSNeutralLow confidence
Context

Neutral sentiment with low relevance; minimal impact expected.

Expected impact

Minimal or no significant movement expected.

Evidence & confidence

Low relevance and neutral sentiment imply limited influence on trading decisions.

Market effects

Potential positive impact on the information technology sector due to undervalued stocks.

Limited regional impact; focus is on US-listed stocks.

Minimal global relevance; primarily US market-focused.

Counterpoint

The oversold conditions may persist or worsen, leading to further declines; technical signals are not foolproof.

Key entities

  • FOXO Technologies

    A technology company focusing on digital health solutions.

  • ClearOne

    A provider of audio and visual communication solutions.

  • InMed Pharmaceuticals

    A biopharmaceutical company, included here for context but with limited relevance.

Related articles

$CLROMedAI 8/10

ClearOne (CLRO) Stock Soars Over 98% After Hours: Here's What You Need To Know ClearOne Shares Surge 98%

ClearOne (CLRO) shares jumped about 98% after hours after a majority stockholder, First Finance Ltd., approved by written consent the issuance of 12.5 million common shares tied to a merger, exceeding 20% of outstanding shares and triggering a change-of-control. The issuance takes effect 20 days after shareholder disclosure. ClearOne canceled First Finance warrants and signed CFO Simon Brewer to a new deal with $300,000 salary and 200,000 options.

$IMOSMedAI 8/10

ChipMOS REPORTS RECORD HIGHEST MONTHLY AND QUARTERLY REVENUE SINCE 2014; REPORTS 37.2% YoY INCREASE IN JUNE 2026 REVENUE; 28.7% YoY INCREASE IN 2Q26 REVENUE

ChipMOS Technologies reported unaudited revenue for June 2026 and 2Q26. June revenue rose 37.2% YoY to NT$2,538.4 million (US$79.7 million). 2Q26 revenue increased 28.7% YoY to NT$7,383.1 million (US$231.8 million), up 6.5% from 1Q26. The company cited AI-related demand-supply tightness and capacity expansion.

$CLROHighAI 9/10

ClearOne Stock Surges 30% On Cortigent Merger Agreement

ClearOne, Inc. (CLRO) shares rose 30.41% to $4.19 on Thursday after the company said it signed a definitive merger agreement under which Vivani Medical’s subsidiary Cortigent will become a wholly owned ClearOne unit. ClearOne plans a $10m–$15m concurrent financing. Cortigent develops implantable neurostimulation technologies.

$CLROMedAI 8/10

ClearOne stock surges 50% on Vivani merger deal By Investing.com

ClearOne Inc (NASDAQ:CLRO) shares rose about 52.6% after it announced a definitive merger with Cortigent Inc, a Vivani Medical Inc (NASDAQ:VANI) subsidiary. Cortigent will become a wholly owned ClearOne unit; Vivani will receive 12.5M CLRO shares. Vivani would own 59.4%-67.5% post-close; ClearOne will rename Cortigent Holdings Inc, expected to trade as CRGT. An S-1 for $10M-$15M is planned; closing expected Q3 2026.

$VANIMedAI 8/10

Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.

Vivani Medical (Nasdaq: VANI) said its subsidiary Cortigent will merge into ClearOne (Nasdaq: CLRO), with Cortigent becoming a wholly owned ClearOne unit. ClearOne plans a concurrent $10–15M financing via an S-1. Vivani will receive 12.5M ClearOne shares for 59.4%–67.5% ownership; ClearOne will rename to Cortigent Holdings (CRGT), expected to close Q3 2026.